These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8332989)

  • 1. ELISA estimation of the binding of epidermolytic toxin to neonatal mouse skin.
    Lockhart BP; Bailey CJ
    Toxicon; 1993 May; 31(5):569-76. PubMed ID: 8332989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidermolytic toxin of Staphylococcus aureus: its failure to bind to cells and its detection in blister fluids of patients with bullous impetigo.
    Baker DH; Dimond RL; Wuepper KD
    J Invest Dermatol; 1978 Oct; 71(4):274-5. PubMed ID: 701847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies on the mechanism of the action of staphylococcal epidermolytic toxin A utilizing recombinant toxin].
    Inaoki M
    Nihon Hifuka Gakkai Zasshi; 1990 Dec; 100(14):1405-14. PubMed ID: 2082042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible binding of epidermolytic toxin to a subcellular fraction of the epidermis.
    Nishioka K; Katayama I; Sano S
    J Dermatol; 1981 Feb; 8(1):7-12. PubMed ID: 7014685
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermolytic toxin binds to components in the epidermis of a resistant species.
    Smith TP; John DA; Bailey CJ
    Eur J Cell Biol; 1989 Aug; 49(2):341-9. PubMed ID: 2476313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence localization of the epidermolytic toxin target in mouse epidermal cells and tissue.
    Lockhart BP; Smith TP; Bailey CJ
    Histochem J; 1991 Sep; 23(9):385-91. PubMed ID: 1720767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays for epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Arbuthnott JP
    Methods Enzymol; 1988; 165():333-8. PubMed ID: 3148097
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro percutaneous penetration and metabolism of [3H]T-2 toxin: comparison of human, rabbit, guinea pig and rat.
    Kemppainen BW; Riley RT; Joyave JL; Hoerr FJ
    Toxicon; 1987; 25(2):185-94. PubMed ID: 3576635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between susceptibility and immune response to staphylococcal exfoliative toxin A in mammalian species.
    Machida K; Sakurai S; Kondo I; Ikawa S
    Microbiol Immunol; 1988; 32(10):1079-84. PubMed ID: 3231130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.
    Amagai M; Matsuyoshi N; Wang ZH; Andl C; Stanley JR
    Nat Med; 2000 Nov; 6(11):1275-7. PubMed ID: 11062541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus.
    Redpath MB; Foster TJ; Bailey CJ
    FEMS Microbiol Lett; 1991 Jun; 65(2):151-5. PubMed ID: 1884990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.
    Eglow R; Pothoulakis C; Itzkowitz S; Israel EJ; O'Keane CJ; Gong D; Gao N; Xu YL; Walker WA; LaMont JT
    J Clin Invest; 1992 Sep; 90(3):822-9. PubMed ID: 1325998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal scalded skin syndrome.
    Gemmell CG
    J Med Microbiol; 1995 Nov; 43(5):318-27. PubMed ID: 7562995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus.
    Bailey CJ; de Azavedo J; Arbuthnott JP
    Biochim Biophys Acta; 1980 Jul; 624(1):111-20. PubMed ID: 6773585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptors of mouse epidermis and dermis.
    Epstein EH; Munderloh NH
    Endocrinology; 1981 Feb; 108(2):703-11. PubMed ID: 7449745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cultured epidermis of human origin for demonstrating the acantholytic action of staphylococcal exfoliatin A].
    Gentilhomme E; Faure M; Arco A; Kanitakis J; Dumaine MH; Marmet D; Binder F; Fleurette J; Thivolet J
    Pathol Biol (Paris); 1988 Feb; 36(2):121-6. PubMed ID: 3279379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1.
    Amagai M; Yamaguchi T; Hanakawa Y; Nishifuji K; Sugai M; Stanley JR
    J Invest Dermatol; 2002 May; 118(5):845-50. PubMed ID: 11982763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity requirements of epidermolytic toxin from Staphylococcus aureus studied by an in vitro assay.
    Smith TP; Bailey CJ
    Toxicon; 1990; 28(6):675-83. PubMed ID: 2119531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological investigations on pathogenesis of staphylococcal scalded skin syndrome].
    Machida K
    Rinsho Byori; 1995 Jun; 43(6):547-56. PubMed ID: 7602798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolytic toxin from Staphylococcus aureus binds to filaggrins.
    Smith TP; Bailey CJ
    FEBS Lett; 1986 Jan; 194(2):309-12. PubMed ID: 2416597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.